AIBILI announces new CEO appointment

AIBILI is pleased to announce the appointment of Daniel Sanches Fernandes as its new Chief Executive Officer, succeeding Cecília Martinho and building on her dedicated leadership and significant contributions to the institution.

With more than 20 years of experience in health research and development, project management, and technology transfer, the new CEO brings strong expertise and a clear vision to further strengthen AIBILI’s role in clinical and translational research. This leadership marks an important step in deepening the institution’s contribution to advancing human health and well-being.

Working closely with AIBILI’s teams and partners, the CEO will continue to focus on transforming research outcomes into impactful innovations that reach people, create value, and generate positive outcomes for the region and beyond.

AIBILI remains committed to collaboration and partnership and welcomes dialogue with organizations and stakeholders interested in joint projects and shared innovation goals.